Evidence map›Paper›PMID 29775389›Full record

SynthesisJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Systematic Review of the Impact of Cancer Survivorship Care Plans on Health Outcomes and Health Care Delivery.

Paul B Jacobsen, Antonio P DeRosa, Tara O Henderson, Deborah K Mayer, Chaya S Moskowitz, Electra D Paskett, Julia H Rowland

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed, 8 pooled it
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 8 syntheses or guidelines pooled it, 264 citations in OpenAlex.

  1. Synthesis of clinical practice guidelines and recommendations for breast cancer survivorship care: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Survivorship care for people affected by advanced or metastatic cancer: MASCC-ASCO standards and practice recommendations.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  3. Pooled it
  4. Health information technology to support cancer survivorship care planning: A systematic review.Journal of the American Medical Informatics Association : JAMIA · 2021
    Pooled it
  5. Breast cancer survivorship in rural settings: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Pooled it
  6. Impact of treatment summaries for cancer survivors: a systematic review.Journal of cancer survivorship : research and practice · 2020
    Pooled it
  7. Pooled it
  8. Guideline
  9. Trial
  10. Trial
  11. Effectiveness of the socioecological informed contextual treatment summary and care plan (TSSCP-P, Brazil) for breast cancer survivors: a randomized, controlled study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Trial
  12. Trial
  13. Feasibility of delivering survivorship care via lay health educators: A pilot randomized controlled trial among rural cancer survivors.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2023
    Trial
  14. Trial
  15. Trial
  16. Trial
  17. Who Enrolls in an Online Cancer Survivorship Program? Reach of the INSPIRE Randomized Controlled Trial for Hematopoietic Cell Transplantation Survivors.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2020
    Trial
  18. The ENHANCES study: a randomised controlled trial of a nurse-led survivorship intervention for patients treated for head and neck cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Trial
  19. Trial
  20. Trial

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Paul B JacobsenPaul B. Jacobsen, National Cancer Institute, Bethesda, MD; Antonio P. DeRosa, Weill Cornell Medicine; Chaya S. Moskowitz, Memorial Sloan-Kettering Cancer Center, New York, NY; Tara O. Henderson, Pritzker School of Medicine, University of Chicago, Chicago, IL; Deborah K. Mayer, University of North Carolina at Chapel Hill, Chapel Hill, NC; Electra D. Paskett, The Ohio State University, Columbus, OH; and Julia H. Rowland, Smith Center for Healing and the Arts, Washington, DC.
Antonio P DeRosaPaul B. Jacobsen, National Cancer Institute, Bethesda, MD; Antonio P. DeRosa, Weill Cornell Medicine; Chaya S. Moskowitz, Memorial Sloan-Kettering Cancer Center, New York, NY; Tara O. Henderson, Pritzker School of Medicine, University of Chicago, Chicago, IL; Deborah K. Mayer, University of North Carolina at Chapel Hill, Chapel Hill, NC; Electra D. Paskett, The Ohio State University, Columbus, OH; and Julia H. Rowland, Smith Center for Healing and the Arts, Washington, DC.
Tara O HendersonPaul B. Jacobsen, National Cancer Institute, Bethesda, MD; Antonio P. DeRosa, Weill Cornell Medicine; Chaya S. Moskowitz, Memorial Sloan-Kettering Cancer Center, New York, NY; Tara O. Henderson, Pritzker School of Medicine, University of Chicago, Chicago, IL; Deborah K. Mayer, University of North Carolina at Chapel Hill, Chapel Hill, NC; Electra D. Paskett, The Ohio State University, Columbus, OH; and Julia H. Rowland, Smith Center for Healing and the Arts, Washington, DC.
Deborah K MayerPaul B. Jacobsen, National Cancer Institute, Bethesda, MD; Antonio P. DeRosa, Weill Cornell Medicine; Chaya S. Moskowitz, Memorial Sloan-Kettering Cancer Center, New York, NY; Tara O. Henderson, Pritzker School of Medicine, University of Chicago, Chicago, IL; Deborah K. Mayer, University of North Carolina at Chapel Hill, Chapel Hill, NC; Electra D. Paskett, The Ohio State University, Columbus, OH; and Julia H. Rowland, Smith Center for Healing and the Arts, Washington, DC.
Chaya S MoskowitzPaul B. Jacobsen, National Cancer Institute, Bethesda, MD; Antonio P. DeRosa, Weill Cornell Medicine; Chaya S. Moskowitz, Memorial Sloan-Kettering Cancer Center, New York, NY; Tara O. Henderson, Pritzker School of Medicine, University of Chicago, Chicago, IL; Deborah K. Mayer, University of North Carolina at Chapel Hill, Chapel Hill, NC; Electra D. Paskett, The Ohio State University, Columbus, OH; and Julia H. Rowland, Smith Center for Healing and the Arts, Washington, DC.
Electra D PaskettPaul B. Jacobsen, National Cancer Institute, Bethesda, MD; Antonio P. DeRosa, Weill Cornell Medicine; Chaya S. Moskowitz, Memorial Sloan-Kettering Cancer Center, New York, NY; Tara O. Henderson, Pritzker School of Medicine, University of Chicago, Chicago, IL; Deborah K. Mayer, University of North Carolina at Chapel Hill, Chapel Hill, NC; Electra D. Paskett, The Ohio State University, Columbus, OH; and Julia H. Rowland, Smith Center for Healing and the Arts, Washington, DC.
Julia H RowlandPaul B. Jacobsen, National Cancer Institute, Bethesda, MD; Antonio P. DeRosa, Weill Cornell Medicine; Chaya S. Moskowitz, Memorial Sloan-Kettering Cancer Center, New York, NY; Tara O. Henderson, Pritzker School of Medicine, University of Chicago, Chicago, IL; Deborah K. Mayer, University of North Carolina at Chapel Hill, Chapel Hill, NC; Electra D. Paskett, The Ohio State University, Columbus, OH; and Julia H. Rowland, Smith Center for Healing and the Arts, Washington, DC.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

Purpose Numerous organizations recommend that patients with cancer receive a survivorship care plan (SCP) comprising a treatment summary and follow-up care plans. Among current barriers to implementation are providers' concerns about the strength of evidence that SCPs improve outcomes. This systematic review evaluates whether delivery of SCPs has a positive impact on health outcomes and health care delivery for cancer survivors. Methods Randomized and nonrandomized studies evaluating patient-reported outcomes, health care use, and disease outcomes after delivery of SCPs were identified by searching MEDLINE, Embase, PsycINFO, Cumulative Index to Nursing and Allied Health Literature, and Cochrane Library. Data extracted by independent raters were summarized on the basis of qualitative synthesis. Results Eleven nonrandomized and 13 randomized studies met inclusion criteria. Variability was evident across studies in cancer types, SCP delivery timing and method, SCP recipients and content, SCP-related counseling, and outcomes assessed. Nonrandomized study findings yielded descriptive information on satisfaction with care and reactions to SCPs. Randomized study findings were generally negative for the most commonly assessed outcomes (ie, physical, functional, and psychological well-being); findings were positive in single studies for other outcomes, including amount of information received, satisfaction with care, and physician implementation of recommended care. Conclusion Existing research provides little evidence that SCPs improve health outcomes and health care delivery. Possible explanations include heterogeneity in study designs and the low likelihood that SCP delivery alone would influence distal outcomes. Findings are limited but more positive for proximal outcomes (eg, information received) and for care delivery, particularly when SCPs are accompanied by counseling to prepare survivors for future clinical encounters. Recommendations for future research include focusing to a greater extent on evaluating ways to ensure SCP recommendations are subsequently acted on as part of ongoing care.

Indexed as

Cancer SurvivorsPatient Care PlanningDelivery of Health CareHumansNeoplasmsRandomized Controlled Trials as TopicTreatment Outcome

Identifiers

PMID29775389
PMCPMC6036622
OpenAlexW2803946275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.